TomTec has received the US Food and Drug Administration's (FDA) 510(k) clearance for its new 2D cardiac performance analysis (CPA) MR software solution.
2D CPA MR is a vendor independent software solution which is designed for the quantification of myocardial function with cardiac MR cine images.
2D CPA MR solution featuring tracking technology is used to track the displacement of myocardial structures over the length of a complete heart cycle.
The software also tracks endo- and epicardium, and describes left ventricular deformation in terms of longitudinal, radial and circumferential components.
TomTec Clinical Products and Innovations vice president Rolf Baumann said 2D CPA MR provides incremental information regarding left ventricular deformation and enhances the diagnostic possibilities.
"With 2D CPA MR, even a comprehensive strain analysis can be fully integrated into your clinical routine workflow," Baumann added.